Close Menu

Qlucore Omics Explorer 3.2

Jan 11, 2016

Qlucore has released Omics Explorer 3.2, the latest version of its data analysis software. The release features improved functionality for clustering and classifying data that help researchers better explore and analyze samples. These tools let researchers segregate samples into distinct clusters and subgroups, and also classify samples using different predictive models. Also included in this release are new plot options including a bar plot option with a range of configurations and the Kaplan-Meier version of the line plot.

More Like This

Dec 05, 2019

InterVenn Biosciences OpenPIP Mass Spectrometry Analysis Software

InterVenn Biosciences has made its proprietary mass spectrometry analysis software available for public use. Powered by artificial intelligence and machine learning, OpenPIP reduces the time and cost of integrating and quantifying mass spec data while increasing the quality of output by eliminating observer-based bias. The software is accessed via the Google Cloud Platform and has demonstrated greater than 99 percent concordance with human peak selection, the company said. A publication detailing the specific neural network architecture is currently undergoing peer review. 

Dec 05, 2019

Dante Labs: Whole GenomeH

Dante Labs has launched Whole GenomeH, a next-generation sequencing-based testing service featuring genome assembly with both long and short read technologies.

The test, which costs $1,999, uses both Illumina NovaSeq and Oxford Nanopore Technologies PromethIon sequencing systems.

Dec 04, 2019

Macrogen: Northeast Asia Reference Database

Macrogen of Korea has released the Northeast Asian Reference Database (NARD). It includes whole-genome sequencing and genetic variant data for a panel of 1,779 individuals, including 850 Koreans, 384 Mongolians, 396 Japanese, 91 Chinese, and 58 Hong Kong residents, making it the largest reference panel representing those countries, according to the company. Macrogen expects the database will help improve the accuracy of imputation in genome-wide association studies and predict disease based on polygenic risk scores. Early next year, the company plans to release a second reference panel, from 10,000 individuals.

Dec 04, 2019

Quadrant Biosciences Clarifi ASD

Quadrant Biosciences has launched Clarifi ASD, an epigenetic test designed to aid in the diagnosis of autism spectrum disorder in children 18 months through six year of age. Quadrant said the test is based on regulatory RNAs and microbes in the saliva, and is the result of seven years of research in collaboration with SUNY Upstate Medical University and Penn State College of Medicine. Clarifi is a prescription-only, laboratory-developed test that is intended to be used as an additional tool to standard practices and only for children with a clinical suspicion of ASD, the company said. It is available in all states except New York.

Dec 03, 2019

SiO2 Materials Synergy Tube

SiO2 Materials Science has launched its Synergy Tube, a blood collection tube designed to optimize nucleic acid recovery and cancer tumor cells (CTCs) after blood draw. The firm said that researchers can extract cfDNA/cfRNA and cellular gDNA/RNA from the same tube, allowing users to pair results from the same sample. 

Nov 27, 2019

Devyser HBOC Kit for Hereditary Breast, Ovarian Cancer Testing

Swedish genetic test developer Devyser has launched the HBOC kit for hereditary breast and ovarian cancer testing. The kit is based on Devyser's proprietary next-generation sequencing library prep technology, and provides targeted sequencing of 12 genes in which mutations are associated with an increased risk of developing breast and ovarian cancer. The company said that the workflow takes less than 45 minutes. The HBOC kit is part of Devyser's NGS Oncology suite, complementing the company's BRCA kit that enables simultaneous screening of mutations in the BRCA1 and BRCA2 genes. The new kit is available in the EU and through Devyser distributors in several countries in the Middle East, Southeast Asia, China, South America, and Africa. Customers in countries in which Devyser does not have distributors currently (e.g. the US and Canada) can self-import the assay, a company spokesperson said.

Nov 26, 2019

10x Genomics: Visium Spatial Gene Expression Solution

10x Genomics has launched its Visium Spatial Gene Expression solution. The assay provides researchers the ability to map where gene activity is occurring in a tissue specimen, with whole-transcriptome analysis of up to hundreds of thousands of cells on a tissue section.

Visium builds on earlier products from Spatial Transcriptomics, which 10x acquired in 2018, offering five times more spots within a capture area while reducing the time it takes from three days to one day.

Visium also includes turn-key software and requires access to an optical microscope.

Nov 22, 2019

Biocept TRK Assay

Biocept said it has launched a new assay for detection of TRK proteins in circulating tumor cells, intended to help inform physicians of patients' NTRK fusion status, an actionable biomarker that can be used to qualify patients for treatment with TRK inhibitor therapies.

The launch brings the company's CLIA lab test menu to 20 assays, including a variety of other single-gene tests analyzed in either circulating cell-free DNA or CTCs, and a next-gen sequencing panel test for lung cancer biomarkers.

Nov 20, 2019

Thermo Fisher Scientific Applied Biosystems SeqStudio Genetic Analyzer for Human Identification

Thermo Fisher Scientific has launched the Applied Biosystems SeqStudio Genetic Analyzer for Human Identification, a capillary electrophoresis platform. The system is designed for small- to medium-sized forensic DNA and paternity laboratories. It has been validated according to Scientific Working Group on DNA Analysis Methods (SWGDAM) guidelines on several Applied Biosystems STR amplification kits. The instrument uses an integrated cartridge that combines a capillary array, polymer reservoir, and anode buffer.

Nov 19, 2019

HTG Molecular Diagnostics EdgeSeq Reveal V 2.0

HTG Molecular Diagnostics has released its HTG EdgeSeq Reveal data analysis software, version 2.0. The Tucson, Arizona-based firm said that the new software contains enhanced functionality, allowing rapid data analysis from the HTG EdgeSeq Autoimmune Panel.

Nov 15, 2019

MedGenome South Asian Research Genotyping Array (SARGAM)

MedGenome has introduced the South Asian Research Genotyping Array, which leverages MedGenome's proprietary database of 2.5 million variants unique to the South Asian population and not available in any publicly available genetic database. MedGenome will use sequence data generated in its facility in Bengaluru, India to continue to identify unique content for SARGAM, which is based on Thermo Fisher Scientific's Applied Biosystems Axiom genotyping arrays. MedGenome said that SARGAM is intended to enable discovery research involving South Asian population cohorts, and will be ideal for consumer genomics solutions like ancestry and pharmacogenomics for the South Asian population.

Nov 15, 2019

Takara Bio Cellartis Intestinal Epithelial Cells Kit

Takara Bio has launched the Cellartis Intestinal Epithelial Cells (from ChiPSC18) Kit. These small intestinal epithelial cells derived from human induced pluripotent stem cells express intestinal markers at levels comparable to that of adult small intestinal tissue. They also express drug metabolizing enzyme CYP3A4 and drug transporter PEPT1 at more physiologically relevant levels compared with Caco-2, the current gold standard of intestinal models, Takara said. Additionally, the monolayer of intestinal epithelial cells forms a functional barrier that can be used for predicting intestinal permeability. The cells provide an improved model for the study of absorption and metabolism of orally administered drugs, the company said.

Nov 15, 2019

CBR ReadyGen Pediatric Genetic Screening Service

CBR, a Los Angeles-based company specializing in newborn stem cell banking, has launched a new genetic service developed in collaboration with Sema4. ReadyGen is a genetic screening test that analyzes a child's DNA for more than 200 conditions that can affect children before the age of 10. These conditions are currently addressable through medication, dietary modification, newborn stem cell transplant, or other therapies, especially when detected early in a child's life, the company said. Parents can order ReadyGen online and all orders will be reviewed and approved by a physician to ensure they are medically appropriate for the child.

Nov 15, 2019

NuProbe VarTrace Sanger Assays

NuProbe Global has launched VarTrace Sanger assays for ultrasensitive detection and quantification of cancer mutations with variant allele frequencies down to 0.1 percent. The company specifically launched three assays covering EGFR mutations for non-small-cell lung cancer; BRAF mutations for melanoma and thyroid cancer; and FLT3, DNMT3A, IDH1, IDH2, KIT, NPM1 mutations for acute myeloid leukemia. The assays are based on the firm's proprietary blocker displacement amplification (BDA) technology, and are compatible with both cell-free DNA from blood plasma and tissue samples including formalin-fixed paraffin-embedded tissue, NuProbe said.

Nov 14, 2019

Loop Genomics Long-Read PCR Amplicon Sequencing Kit, Service

Loop Genomics has launched a new amplicon library prep kit and service for generating synthetic long sequence reads from long PCR amplicons on Illumina sequencers. The kit can be used for PCR fragments up to 3 kb in size and the service can process orders for PCR fragments up to 6 kb long.

Nature News reports that gene therapy approaches are tackling sickle cell disease, but that the cost of treatment is a concern.

The Washington Post reports that a US Senate committee voted this week to approve the nomination of Stephen Hahn to lead the Food and Drug Administration.

One gene regulates hundreds of others to influence facial development, according to New Scientist.

In Nature this week: resources for single-cell analysis, little overlap in the microRNAs used by Salmonella and Shigella to infect host cells, and more.

Dec
10
Sponsored by
Congenica II

This webinar will discuss the use of next-generation sequencing and an optimized variant interpretation workflow to increase diagnostic yield in complex clinical cases.

Dec
11
Sponsored by
Roche

This webinar will address how two molecular laboratories are implementing tertiary analysis software to improve their precision oncology workflows.